pharma · Pulmonary Embolism · Carcinoma, Hepatocellular
Bayer HealthCare Animal
Bayer HealthCare AG
Bayer HealthCare Animal clinical programs — 5 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 3915 S 48TH STREET TER, St. Joseph, Missouri 64503, us
- Founded
- 1919
- Employees
- 8
- Programs
- 34
- Drugs
- 32
- Patents
- 24
Bayer HealthCare Animal projects
5 ClinicalTrials.gov programs sponsored by Bayer HealthCare Animal.
Bayer HealthCare Animal has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
91396
Bayer HealthCare AG
Magnetic Resonance Angiography
1 trial -
BAY1002670
Bayer HealthCare AG
Leiomyoma
1 trial -
BAY2757556 (Larotrectinib, Vitrakvi)
Bayer HealthCare AG
Solid Tumors Harboring NTRK Fusion
1 trial -
Radium-223 dichloride (Xofigo, BAY88-8223)
Bayer HealthCare AG
Breast Neoplasms
1 trial -
Sorafenib (Nexavar, BAY43-9006) plus Doxorubicin
Bayer HealthCare AG
Carcinoma, Hepatocellular
1 trial
Frequently asked questions
How many clinical projects does Bayer HealthCare Animal have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.